Genmab — April 2023
-
Godmorgen

-
Jeps...kan godt se ud til der bliver råd til en Heineken eller 2 til fyraften:-D
-
-
Det har da været et par dage med godt gang i kursen
-
Session LBPO.IM02 - Late-Breaking Research: Immunology 2
LB209 / 2 - An ADC composed of daratumumab and lenalidomide is extremely powerful in killing multiple myeloma cells https://www.abstractsonline.com/pp8/#!/10828/presentation/9729 -
GEN1042 (DuoBody-CD40x4-1BB)
in combination with PD-1 blockade reverses T-cell exhaustion in vitro https://www.abstractsonline.com/pp8/#!/10828/presentation/4744
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind